Prospective, Non-Interventional,Multicentre study With Neo-Angin Benzydamine, 3 Mg Lozenges For Treatment Of Acute Sore Throat, Lemon Flavour, To Evaluate The Tolerability, Acceptance And Course Of Symptoms In The Treatment Of Acute Sore Throat In Adult Patients

Jürgen Palm, Bettina Schopf, Holger Stammer,Nadja Schughart

Objective: To evaluate the tolerability, acceptance and course of symptoms in the treatment of acute sore throat with neo-angin® benzydamine, 3 mg lozenges for treatment of ..Ver más»

Two New Cycloartenol and Some Pentacyclic Triterpenoids from Cameroonian Propolis (Ngaoundal, AD Region) and Evaluation of their Antimicrobial Activity

Sakava Paul, Tagatsing Fotsing Maurice, Zeuko’o Menkem Elisabeth, Talla Emmanuel, Laurent Sophie, Celine Hénoumont, Vander Elst Luce, Awantu Fusi Angelbert, Atchadé Alex de Théodore and Mbafor Tanyi Joseph

The objective of this study was the isolation, the structure elucidation and the identification of chemical constituents from the n-hexane, the ethyl acetate (EtOAc) and the met..Ver más»

Review on the CURRENT STUDY ON BIOLOGICAL AND SYNTHETIC APPLICATIONS OF ARYL PYRIMIDINES

Boja Poojary

Pyrimidine is a hetero-aromatic compound containing two nitrogen atoms at positions 1 and 3 of the six-membered ring which shows a wide range of biological properties. Pyrimidin..Ver más»

Adrenal Cortisol Hyper-Responsiveness as a Possible Cause of Obesity, Insulin Resistance and Cardiovascular Risk

Yadon Arad, Simcha Pollack, Marguerite Roth and Alan D Guerci

Introduction: Increased

cortisol

concentrations due to endogenous over-secretion or exogenous administration result in obesity, insulin resistance, and incre..Ver más»

Differential Role of AMP-Activated Protein Kinase in Brown and White Adipose Tissue Components and Its Consequences in Metabolic Diseases

Monireh Dashty

The LKB1/AMPK/TSC/mTORC1 cassette constitutes a canonical signaling pathway that integrates the metabolic and nutrient status of the cell for regulation of cell growth and survi..Ver más»

Orally-Administered Chemokine Receptor CCR2 Antagonist CCX140-B in Type 2 Diabetes: A Pilot Double-Blind, Randomized Clinical Trial

Markolf Hanefeld, Ernest Schell, Ioanna Gouni-Berthold, Martin Melichar, Ivana Vesela, Dan Johnson, Shichang Miao, Tim J Sullivan, Juan C Jaen, Thomas J Schall, Pirow Bekker and The CCX140-B Diabetes Study Group

Study background: Inflammatory macrophages expressing the C-C chemokine receptor 2 (CCR2) accumulate in adipose tissue and contribute to insulin resistance. CCX140-B is an orall..Ver más»